Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
13 août 2024 07h30 HE
|
Insignis Therapeutics, Inc.
Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
13 août 2024 07h10 HE
|
atai Life Sciences
atai Reports Q2 2024 Financial Results and Corporate Updates
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
13 août 2024 07h00 HE
|
atai Life Sciences
VLS-01 demonstrated a good safety and tolerability profile and a short psychedelic experience, enabling a total in-clinic treatment of two hours.
Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
12 août 2024 11h00 HE
|
Zealand Pharma
Press Release – No. 8 / 2024 Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results Copenhagen, Denmark, August 12,...
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
09 août 2024 16h20 HE
|
Edesa Biotech, Inc.
TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
08 août 2024 19h20 HE
|
HilleVax, Inc.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine...
Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
08 août 2024 10h15 HE
|
Medigene AG
Planegg/Martinsried, August 8, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Canada's First Precision Health and Longevity Summit Aims to Advance Global Healthspan Research
08 août 2024 09h47 HE
|
BioAro
Join Canada’s first Precision Health & Longevity Summit on Nov 16, 2024, at The Westin Calgary. Explore innovations in precision medicine & healthspan.
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 août 2024 08h00 HE
|
Phathom Pharmaceuticals
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly reportNet revenues of $7.3 million reported for the second...
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
08 août 2024 08h00 HE
|
Fractyl Health, Inc.
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single